Progress in Cardiovascular Diseases

Top Research Topics at Progress in Cardiovascular Diseases?

Progress in Cardiovascular Diseases mainly tackles studies in Internal medicine, Cardiology, Intensive care medicine, Surgery and Disease. Research on Internal medicine addressed in the journal frequently intersections with the field of Endocrinology. The journal connects research in Cardiology with the related topic of Anesthesia.

The journal explores topics in Intensive care medicine which can be helpful for research in disciplines like Clinical trial and MEDLINE. Progress in Cardiovascular Diseases features Disease research that overlaps with concepts in Physical therapy.

• Internal medicine (50.12%)
• Cardiology (41.34%)
• Intensive care medicine (18.44%)

What are the most cited papers published in the journal?

• Beta blockade during and after myocardial infarction: an overview of the randomized trials (2750 citations)
• Blood flow measurements with radionuclide-labeled particles. (1895 citations)
• Natural history of pulmonary embolism (964 citations)

Research areas of the most cited articles at Progress in Cardiovascular Diseases:

The journal publications focus on Internal medicine, Cardiology, Intensive care medicine, Heart failure and Disease. The published articles connects the study in Internal medicine with the closely related areas of Endocrinology. The published papers focus on Cardiology but the discussions also offer insight into other areas such as Anesthesia and Diastole.

What topics the last edition of the journal is best known for?

• Internal medicine
• Disease
• Surgery

The previous edition focused in particular on these issues:

The main points discussed in Progress in Cardiovascular Diseases deals with Internal medicine, Cardiology, Disease, Intensive care medicine and Coronavirus disease 2019 (COVID-19). Confidence interval, Prospective cohort study, Risk factor, Cardiorespiratory fitness and Randomized controlled trial are Internal medicine topics of special interest in Progress in Cardiovascular Diseases. Progress in Cardiovascular Diseases tackles research works in Cardiology as well as In patient.

It deals with Disease in conjunction with Psychological intervention and similar fields in Behavior change and Sitting. Topics in Intensive care medicine were tackled in line with various other fields like Clinical trial, Epidemiology, Restenosis, Myocardial infarction and Thrombosis. The presented studies in Pandemic fall within the purview of Coronavirus disease 2019 (COVID-19) but it also intertwines with topics in 2019-20 coronavirus outbreak.

The most cited articles from the last journal are:

• A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? (231 citations)
• Physical activity for immunity protection: Inoculating populations with healthy living medicine in preparation for the next pandemic. (81 citations)
• The global food syndemic: The impact of food insecurity, Malnutrition and obesity on the healthspan amid the COVID-19 pandemic. (34 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Progress in Cardiovascular Diseases (based on the number of publications) are:

• Carl J. Lavie (103 papers) published 19 papers at the last edition, 2 more than at the previous edition,
• Ross Arena (55 papers) published 16 papers at the last edition, 13 more than at the previous edition,
• Richard V. Milani (21 papers) published 1 paper at the last edition the same number as at the previous edition,
• Ulrik Wisløff (21 papers) published 3 papers at the last edition, 1 less than at the previous edition,
• Hector O. Ventura (20 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Progress in Cardiovascular Diseases (based on the number of publications) are:

• University of Queensland (133 papers) published 21 papers at the last edition the same number as at the previous edition,
• Harvard University (101 papers) published 5 papers at the last edition the same number as at the previous edition,
• University of Illinois at Chicago (85 papers) published 20 papers at the last edition, 15 more than at the previous edition,
• Columbia University (66 papers) published 1 paper at the last edition,
• Mayo Clinic (62 papers) published 4 papers at the last edition, 5 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.13% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 58.70% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.52% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 5.43% of all publications and 29.35% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Impact and Relevance of Cardiovascular Disease Research in Medical Education

In addition to its significance in advancing medical knowledge and treatments, the research conducted and published in Progress in Cardiovascular Diseases plays a vital role in medical education, particularly in specialized areas such as cardiology and internal medicine. The effect of cardiology related research, with a specific focus on cardiovascular diseases, extends beyond direct patient care and influences the structure and content of both undergraduate and postgraduate medical curriculums. By driving educational developments in these areas, cutting-edge research findings ensure that future medical professionals are equipped with the latest knowledge and skills to manage and treat cardiovascular conditions effectively. Moreover, in the era of online education driven by technological advancements, the importance of integrating these research findings into online educational programs cannot be overstated. For instance, online nursing schools in best online nursing programs in Nevada utilize these research studies to update their course content and teaching methods. This approach provides nursing students with a relevant and contemporary understanding of cardiovascular diseases, setting a strong foundation for their future clinical practice. The transformative findings published in Progress in Cardiovascular Diseases ensure that the next generation of healthcare professionals, whether they are studying in traditional settings or via online platforms, are thoroughly prepared to make significant contributions to patient care and further research in the field of Cardiovascular Diseases.